We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Low-Level Presence of New GM Crops: An Issue on the Rise for Countries Where They Lack Approval

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Low-Level Presence of New GM Crops: An Issue on the Rise for Countries Where They Lack Approval"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
- Alexander J. Stein and Emilio Rodríguez-Cerezo. AgBioForum, 13(2), 173-182.

This study addresses a new issue in the commercialization of GM crops, namely the occurrence of traces—or “low-level presence” (LLP)—of nationally unapproved GM material in crop imports. The commercialization of GM crops is a regulated activity, and countries have different authorization procedures. Hence, new GM crops are not approved simultaneously. This “asynchronous approval” (AA), in combination with a “zero-tolerance” policy towards LLP, is of growing concern for its potential economic impact on international trade.

To forecast the future evolution of this issue, we compiled a global pipeline of GM crops that may be commercialized by 2015. This pipeline is analyzed by crop and likely LLP scenarios are discussed. While currently there are about 30 commercial GM crops with different transgenic events worldwide, it is expected that by 2015 there will be more than 120. Given that problems of LLP have already occurred with the 30 current events, these issues are likely to intensify when more events become available in more countries.  (European Commission, Joint Research Centre, Institute for Prospective Technological Studies )